BioWorld MedTech

Sep. 20, 2013

Crosstrees gains FDA clearance for PVA device

Crosstrees Medical (Boulder, Colorado) reported that it has received 510(k) clearance from the FDA for the Crosstrees PVA Pod System for Percutaneous Vertebral Augmentation (PVA). Read More

Agilent Technologies to split into two public companies

Device China annual conference: China device association calls for government guidance

Washington roundup: ReSure hits efficacy endpoint; protocol deviations a problem

Financings roundup: Infraredx gets $25M TVC imagingsystem investment from Nipro

Agreements/contracts: Ventana collaborates with Boehringer for diagnostics

Restructuring roundup: Citing ACA, Cleveland Clinic to cut $300M, warns of layoffs

Court report: Alleged secret deal finds Boston Sci facing hefty suit

HIT roundup: Bruker unveils ParaVision 6 preclinical MRI software

Deals roundup: IPC in plan to acquire the assets of MPHM

Med-Tech Notes

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...